Contact
searchSearch
HMP Global

April 2013 - FRMC

Department
Oral Therapy for Chronic Weight Management - Qsymia® (phentermine and topiramate extended-release) capsules
04/22/2013
The FDA approved Qsymia® (phentermine and topiramate extended-release) capsules in July 2012 as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in people with a body mass index ≥30 kg/m2...
The FDA approved Qsymia® (phentermine and topiramate extended-release) capsules in July 2012 as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in people with a body mass index ≥30 kg/m2...
The FDA approved Qsymia®...
04/22/2013
First Report Managed Care
Department
Infliximab for Treatment-Resistant Depression
04/22/2013
About one third of depressed patients fail to respond to conventional antidepressant medication. It is believed that inflammation is a possible mechanism that contributes to this treatment resistance. A number of inflammatory biomarkers...
About one third of depressed patients fail to respond to conventional antidepressant medication. It is believed that inflammation is a possible mechanism that contributes to this treatment resistance. A number of inflammatory biomarkers...
About one third of depressed...
04/22/2013
First Report Managed Care
Cardiovascular Events and Polycythemia Vera
04/22/2013
Polycythemia vera is a rare hematologic neoplasm characterized by clonal proliferation of multipotent bone marrow progenitors, leading to abnormal production of erythroid cells and an increased red-cell mass. Acquired mutations in JAK2 (JAK2...
Polycythemia vera is a rare hematologic neoplasm characterized by clonal proliferation of multipotent bone marrow progenitors, leading to abnormal production of erythroid cells and an increased red-cell mass. Acquired mutations in JAK2 (JAK2...
Polycythemia vera is a rare...
04/22/2013
First Report Managed Care
Costs of Biologics to Treat Psoriasis
04/22/2013
Miami Beach—During a 10-year period, the average direct costs per patient with moderate-to-severe psoriasis who took biologics were nearly $200,000 regardless of the drug they were prescribed, while productivity losses averaged around...
Miami Beach—During a 10-year period, the average direct costs per patient with moderate-to-severe psoriasis who took biologics were nearly $200,000 regardless of the drug they were prescribed, while productivity losses averaged around...
Miami Beach—During a 10-year...
04/22/2013
First Report Managed Care
Analysis of Acitretin to Treat Psoriasis
04/22/2013
Miami Beach—An analysis of national survey data found that patients with psoriasis typically use acitretin in combination with other agents. However, women of childbearing potential are typically not prescribed the drug due to serious side...
Miami Beach—An analysis of national survey data found that patients with psoriasis typically use acitretin in combination with other agents. However, women of childbearing potential are typically not prescribed the drug due to serious side...
Miami Beach—An analysis of...
04/22/2013
First Report Managed Care
Patients with TTR Amyloidosis Using Pacemakers
04/22/2013
San Francisco—Patients with transthyretin (TTR) amyloidosis who had pacemakers were more likely to be older and male, and have greater beta-blocker use, greater left ventricular septal thickness, and higher brain natriuretic peptide levels...
San Francisco—Patients with transthyretin (TTR) amyloidosis who had pacemakers were more likely to be older and male, and have greater beta-blocker use, greater left ventricular septal thickness, and higher brain natriuretic peptide levels...
San Francisco—Patients with...
04/22/2013
First Report Managed Care
PCI versus Pharmaco-Invasive Regimen in STEMI Patients
04/22/2013
San Francisco—Patients with ST-elevation myocardial infarction (STEMI) treated at community hospitals or in ambulances had similar results whether they underwent percutaneous coronary intervention (PCI) or received a pharmaco-invasive...
San Francisco—Patients with ST-elevation myocardial infarction (STEMI) treated at community hospitals or in ambulances had similar results whether they underwent percutaneous coronary intervention (PCI) or received a pharmaco-invasive...
San Francisco—Patients with...
04/22/2013
First Report Managed Care
Integrated Healthcare System’s Effect on Clinical and Economic Results
04/22/2013
San Francisco—A retrospective cohort study found that for patients with atrial fibrillation and atrial flutter, a closed system healthcare model was associated with significantly lower costs compared with an open system model over a 12-month...
San Francisco—A retrospective cohort study found that for patients with atrial fibrillation and atrial flutter, a closed system healthcare model was associated with significantly lower costs compared with an open system model over a 12-month...
San Francisco—A retrospective...
04/22/2013
First Report Managed Care
Ranolazine for Type 2 Diabetes, Coronary Artery Disease, and Chronic Stable Angina
04/22/2013
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type...
04/22/2013
First Report Managed Care
Eplerenone in STEMI Patients with No History of Heart Failure
04/22/2013
San Francisco—After a mean follow-up of 10.5 months, patients with acute ST-segment elevation myocardial infarction (STEMI) who, having no diagnosis of heart failure, took eplerenone in addition to standard treatment had a significant...
San Francisco—After a mean follow-up of 10.5 months, patients with acute ST-segment elevation myocardial infarction (STEMI) who, having no diagnosis of heart failure, took eplerenone in addition to standard treatment had a significant...
San Francisco—After a mean...
04/22/2013
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Biotechnology Initial Public Offerings Soar in 2013
02/13/2014
New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity in the sector since 2000, and...
New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity in the sector since 2000, and...
New York—After several poor...
02/13/2014
First Report Managed Care
News
Study: Pediatric Patients Benefit From PCMH Utilization
03/22/2017
Researchers argue that public funding efforts should be invested in improving the use of patient centered medical homes for children covered under public insurance, or those who have no insurance at all.
Researchers argue that public funding efforts should be invested in improving the use of patient centered medical homes for children covered under public insurance, or those who have no insurance at all.
Researchers argue that public...
03/22/2017
First Report Managed Care
News
High Deductible Health Plans Associated With No Change in Asthma Care
10/26/2021
Authors noted that enrollment in high deductible health plans “was associated with minimal or no reductions in controller medication use for children and adults and no change in asthma exacerbations,” suggesting a potential benefit from...
Authors noted that enrollment in high deductible health plans “was associated with minimal or no reductions in controller medication use for children and adults and no change in asthma exacerbations,” suggesting a potential benefit from...
Authors noted that enrollment in...
10/26/2021
First Report Managed Care
Cancer Screening Cessation for Older Adults
06/26/2013
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
There are many educational...
06/26/2013
First Report Managed Care
News
Mylan gets approval for generic Effexor XR
06/08/2011
06/08/2011
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

April 2013 Volume 10 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use